| Health / Medical Topics |
Pidilizumab
A humanized monoclonal antibody directed against human PD-1 (programmed cell death 1; PDCD1), with immunomodulating and antitumor activities. Pidilizumab blocks interaction between the receptor PD-1 with its ligands, PD-1 ligand 1 (PD-1L1) and PD-1 ligand 2 (PD-1L2), resulting in the attenuation of apoptotic processes in lymphocytes, primarily effector/memory T cells, and the augmentation of the anti-tumor activities of NK cells. PD-1 is an inhibitory receptor belonging to the B7-receptor family that is expressed on lymphocytes and myeloid cells; its ligands, PD-1L1 and PD-1L2, are expressed not only by hematopoietic cells but also by cells in non-lymphoid tissues. (NCI Thesaurus)
YOU MAY ALSO LIKE
A condition in which the female reproductive organs are inflamed. It may affect the uterus, fallopian tubes, ovaries, and certain ligaments. PID…
Picture Archiving and Communication System: A network established to provide access, storage and retrieval of images from medical imaging instrumentation.
A visual representation of an object, scene, person or abstraction.
A cyclolignan alkaloid found in the mayapple plant family (Podophyllum peltatum), and a small molecule inhibitor of the insulin-like growth factor 1…
A quassinoid glycoside phytochemical isolated from the plant Picrasma ailanthoides with potential antineoplastic activity.
A unit of time equal to one trillionth of a second.
